Lee Kevin Freeman's most recent trade in Health Catalyst Inc was a trade of 4,747 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.63 per share. | 02 Jun 2025 | 4,747 | 379,665 (1%) | 0% | 3.6 | 17,254 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 03 Mar 2025 | 10,800 | 384,412 (1%) | 0% | 4.6 | 49,433 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 140,000 | 376,950 (1%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 18,262 | 395,212 (1%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.97 per share. | 01 Dec 2024 | 11,431 | 244,450 (0%) | 0% | 9.0 | 102,573 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 01 Dec 2024 | 7,500 | 236,950 (0%) | 0% | 8.9 | 67,073 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 03 Sep 2024 | 7,500 | 255,881 (0%) | 0% | 7.2 | 54,174 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.27 per share. | 03 Sep 2024 | 2,772 | 263,381 (0%) | 0% | 7.3 | 20,150 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 11 Jun 2024 | 7,500 | 266,153 (0%) | 0% | 6.5 | 49,008 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.53 per share. | 03 Jun 2024 | 2,951 | 273,653 (0%) | 0% | 6.5 | 19,280 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.05 per share. | 01 Mar 2024 | 4,540 | 276,604 (0%) | 0% | 8.1 | 36,552 | Common Stock |
| Health Catalyst Inc | Freeman Kevin Lee | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 110,000 | 277,810 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Lee Kevin Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 3,334 | 281,144 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Lee Kevin Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.45 per share. | 01 Dec 2023 | 2,921 | 167,810 (0%) | 0% | 7.5 | 21,762 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.24 per share. | 01 Jun 2023 | 1,038 | 179,191 (0%) | 0% | 11.2 | 11,666 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,819 | 179,665 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.29 per share. | 01 Mar 2023 | 1,569 | 177,846 (0%) | 0% | 14.3 | 22,419 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 1,264 | 180,929 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.65 per share. | 01 Dec 2022 | 2,446 | 179,415 (0%) | 0% | 10.6 | 26,049 | Common Stock |
| Health Catalyst Inc | Kevin Lee Freeman | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2022 | 120,000 | 181,861 (0%) | 0% | 0 | Common Stock |